Beam Therapeutics
BEAM
BEAM
250 hedge funds and large institutions have $2.58B invested in Beam Therapeutics in 2026 Q1 according to their latest regulatory filings, with 55 funds opening new positions, 89 increasing their positions, 61 reducing their positions, and 40 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
0.97% more ownership
Funds ownership: 105.31% → 106.27% (+0.97%)
13% less capital invested
Capital invested by funds: $2.96B → $2.58B (-$384M)
33% less funds holding in top 10
Funds holding in top 10: 6 → 4 (-2)
Holders
250
Holding in Top 10
4
Calls
$15.8M
Puts
$7.68M
Top Buyers
| 1 | +$40.1M | |
| 2 | +$34.5M | |
| 3 | +$22.8M | |
| 4 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
+$19M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
+$15.1M |
Top Sellers
| 1 | -$27.5M | |
| 2 | -$22.4M | |
| 3 | -$16.2M | |
| 4 |
NAMA
Nikko Asset Management Americas
New York
|
-$16.2M |
| 5 |
Voloridge Investment Management
Jupiter,
Florida
|
-$13.7M |
